Product Information
XOPENEX HFA 45 MCG INHALER is a brand product labeled by Lupin Pharmaceuticals Inc., priced at $4.9891 per GM under NDC 27437005601. Its NADAC has been published 140 times since Dec 20, 2023.
FDA first approved this application on Mar 11, 2005.
Strength
45 ug/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
27437005601
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVALBUTEROL TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA021730FDA Approved
3/11/2005
On Market Since
11/10/2023
Pharmacological Classes
Price Statistics
The NADAC for XOPENEX HFA 45 MCG INHALER has been published 140 times since Dec 20, 2023, and over the history we have for it it has risen 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9891 per GM |
|---|---|
| All-time high | $5.0542 (Jun 10, 2026) |
| All-time low | $4.4395 (Apr 17, 2024) |
| 52-week high | $5.0542 |
| 52-week low | $4.7745 |
| Median price | $4.7861 |
| Average price | $4.7706 |
| Largest weekly change | +5.0% (Aug 28, 2024) |
| Weeks tracked | 140 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XOPENEX HFA 45 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for XOPENEX HFA 45 MCG INHALER, manufactured by Lupin Pharmaceuticals Inc., is $4.9891 per GM (NDC 27437005601), effective Aug 19, 2026.
How has the price of XOPENEX HFA 45 MCG INHALER changed over time?
Over the history we have for it, the NADAC for XOPENEX HFA 45 MCG INHALER has risen 8.9%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for XOPENEX HFA 45 MCG INHALER?
Since Dec 20, 2023, the NADAC for XOPENEX HFA 45 MCG INHALER has ranged from a low of $4.4395 (Apr 17, 2024) to a high of $5.0542 (Jun 10, 2026), with a median of $4.7861 per GM.
Are there cheaper alternatives to XOPENEX HFA 45 MCG INHALER?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVALBUTEROL TAR HFA 45 MCG INH, is $3.4971 per GM — about 30% below XOPENEX HFA 45 MCG INHALER.
Who manufactures XOPENEX HFA 45 MCG INHALER?
XOPENEX HFA 45 MCG INHALER (NDC 27437005601) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a brand product.